CT55
Cancer/testis antigen 55
Also known as: CT55_HUMAN, CXorf48, FLJ20527
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WUE5
- Gene
- CT55
- Ensembl
- ENSG00000169551
- Chromosome
- X
- Canonical length
- 264 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Involved in spermatogenesis. Located in acrosomal vesicle and sperm flagellum. Implicated in X-linked spermatogenic failure 7. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
264 residues, UniProt reviewed canonical sequence.
>Q8WUE5|CT55
1 MLRLLRLALA FYGRTADPAE RQGPQQQGLP QGDTQLTTVQ GVVTSFCGDY GMIDESIYFS
61 SDVVTGNVPL KVGQKVNVVV EEDKPHYGLR AIKVDVVPRH LYGAGPSDSG TRVLIGCVTS
121 INEDNIYISN SIYFSIAIVS EDFVPYKGDL LEVEYSTEPG ISNIKATSVK PIRCIHTEEV
181 CITSVHGRNG VIDYTIFFTL DSVKLPDGYV PQVDDIVNVV MVESIQFCFI WRAISITPVH
241 KSSSGFQDDG GLGRPKRERR SQSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CT55 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 3.6 nTPM
Expression across tissuesHPA
Tissue
- testis: 3.6 nTPM
- basal ganglia: 0.3 nTPM
- cerebral cortex: 0.3 nTPM
- hippocampal formation: 0.3 nTPM
- amygdala: 0.2 nTPM
- hypothalamus: 0.2 nTPM
Single-cell type
- early primary spermatocytes: 16 nCPM
- differentiating spermatogonia: 7.8 nCPM
- adipocytes: 2.7 nCPM
- brain inhibitory neurons: 0.9 nCPM
- cardiomyocytes: 0.7 nCPM
- other brain neurons: 0.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.7 nTPM
- hippocampal formation: 1.1 nTPM
- amygdala: 1 nTPM
- basal ganglia: 1 nTPM
- white matter: 1 nTPM
- thalamus: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CT55.
Disease | AllUniProt
Conditions CT55 is implicated in, by any mechanism.
- Spermatogenic failure, X-linked, 7 (SPGFX7) MIM:301106
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 14 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on CT55 was assayed in.
- chronic myeloid leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.49
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CT55 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CT55 as an antibody target. Whether an autoantibody or antibody against CT55 could matter depends on whether native CT55 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CT55 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CT55 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...